Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2254504 | 0.80 | NPC1 (0.48) | NPC1MAPTRAB9A | |
| SCHEMBL18742977 | 0.80 | ESR1 (0.45) | ESR1ESR2IDO1NPC1MAPT | |
| SCHEMBL19200293 | 0.77 | TSHR (0.55) | ESR1ESR2IDO1ALDH1A1NPC1 | |
| SCHEMBL68287 | 0.75 | ESR1 (0.62) | ESR1ESR2ALDH1A1CYP3A4AR | |
| SCHEMBL7045232 | 0.75 | MAPT (0.53) | ESR1ESR2ALDH1A1CYP3A4NPC1 | |
| SCHEMBL4787209 | 0.75 | MEN1 (0.52) | ESR1ESR2 | |
| SCHEMBL21189697 | 0.75 | — | — | |
| SCHEMBL284909 | 0.74 | TAAR1 (0.48) | ESR1ESR2ALDH1A1CYP3A4MAPT | |
| SCHEMBL24041245 | 0.73 | ESR1 (0.33) | ESR1ESR2IDO1NPC1MAPT | |
| Methyl Alcohol SCHEMBL28148921 | 0.73 | ESR1 (0.60) | ESR1ESR2ALDH1A1CYP3A4AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3626702-B1 | CARBONATE DERIVATIVE PRODUCTION METHOD | UNIV KOBE NAT UNIV CORP (JP) | 2023-02-15 | — | — | EP | disclosed |
| US-11130728-B2 | Carbonate derivative production method | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2021-09-28 | — | — | US | disclosed |
| EP-3626702-A1 | CARBONATE DERIVATIVE PRODUCTION METHOD | National University Corporation Kobe University (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-20200079723-A1 | CARBONATE DERIVATIVE PRODUCTION METHOD | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2020-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079723-A1 | CARBONATE DERIVATIVE PRODUCTION METHOD | CA4, CA14, CA3 | ESR1 2049/4885ESR2 1968/4885IDO1 1164/4885 |
| US-11130728-B2 | Carbonate derivative production method | CA4, CA14, CA3 | ESR1 2049/4885ESR2 1968/4885IDO1 1164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.